These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14563576)

  • 1. Percutaneous treatment of saphenous vein graft disease: the ongoing challenge.
    Baim DS
    J Am Coll Cardiol; 2003 Oct; 42(8):1370-2. PubMed ID: 14563576
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts.
    Schächinger V; Hamm CW; Münzel T; Haude M; Baldus S; Grube E; Bonzel T; Konorza T; Köster R; Arnold R; Haase J; Probst P; vom Dahl J; Neumann FJ; Mudra H; Hennen B; Thiele L; Zeiher AM;
    J Am Coll Cardiol; 2003 Oct; 42(8):1360-9. PubMed ID: 14563575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
    Stone GW; Goldberg S; O'Shaughnessy C; Midei M; Siegel RM; Cristea E; Dangas G; Lansky AJ; Mehran R
    JACC Cardiovasc Interv; 2011 Mar; 4(3):300-9. PubMed ID: 21435608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vessel diameter should be taken into account in saphenous stenting.
    Lozano I; Rondan J; Avanzas P
    EuroIntervention; 2010 Apr; 5(8):991-3. PubMed ID: 20542787
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-ST-segment elevation myocardial infarction related to vulnerable neoatheroma in bare-metal stents 2 years after percutaneous coronary intervention of a coronary saphenous vein graft.
    Roleder T; Wańha W; Smolka G; Ochała A; Wojakowski W
    JACC Cardiovasc Interv; 2014 Aug; 7(8):e95-6. PubMed ID: 25086848
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of post-stenotic saphenous vein graft aneurysm: special considerations with the polytetrafluoroethylene-covered stent.
    Ho PC; Leung CY
    J Invasive Cardiol; 2004 Oct; 16(10):604-5. PubMed ID: 15505363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DES for SVG stenosis -- we all want to do it, but are we there yet?
    Smith CS; Yeghiazarians Y
    J Invasive Cardiol; 2007 Oct; 19(10):410-1. PubMed ID: 17906341
    [No Abstract]   [Full Text] [Related]  

  • 8. The MGuard stent: current promises and limitations.
    Kornowski R
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):642-3. PubMed ID: 20333654
    [No Abstract]   [Full Text] [Related]  

  • 9. Saphenous vein graft intervention discussion on acute vein graft occlusion intervention.
    Poon K; Roati A; Walters DL
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1250; author reply 1250-1. PubMed ID: 22115669
    [No Abstract]   [Full Text] [Related]  

  • 10. Percutaneous bail-out treatment of vein graft rupture with a polytetrafluoroethylene-covered stent.
    Pavlidis AN; Karamasis GV; Clapp BR
    Acute Card Care; 2013 Dec; 15(4):95-6. PubMed ID: 24160712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The final answer? For the treatment of saphenous vein graft disease, drug-eluting stents vs. bare-metal stents.
    Michishita I
    Circ J; 2011; 75(2):261-2. PubMed ID: 21228495
    [No Abstract]   [Full Text] [Related]  

  • 12. Distal embolization after net protective stent (MGUARD) implantation in a degenerated saphenous vein graft lesion.
    Yassin I; Thuesen L
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):639-41. PubMed ID: 20091812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary management of vein graft disease.
    Hermiller J
    J Invasive Cardiol; 2005 Aug; 17(8):399-400. PubMed ID: 16079442
    [No Abstract]   [Full Text] [Related]  

  • 14. Are our patients better off with drug-eluting stents in saphenous vein grafts?
    Douglas JS
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1113-5. PubMed ID: 19926053
    [No Abstract]   [Full Text] [Related]  

  • 15. Occlusion of the saphenous vein graft at the site of polytetrafluoroethylene membrane-covered stent implantation: was it late thrombosis?
    Toutouzas K; Takagi T; Colombo A
    J Invasive Cardiol; 2003 Dec; 15(12):722-4. PubMed ID: 14660828
    [No Abstract]   [Full Text] [Related]  

  • 16. Peptide-treated stent graft for the treatment of saphenous vein graft lesions: first clinical results.
    Hamm CW; Schäachinger V; Münzel T; Maikowski C; Bonzel T; Köster R; Rau M; Zeiher AM
    J Invasive Cardiol; 2003 Oct; 15(10):557-60. PubMed ID: 14519886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What can we do for patients undergoing saphenous vein graft interventions?
    Brilakis ES; Banerjee S
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):30-1. PubMed ID: 21681890
    [No Abstract]   [Full Text] [Related]  

  • 18. PTCA of degenerated vein grafts: experience of two periods (1992-93 and 1996-97) in 780 patients.
    Reifart N; Störger H; Schwarz F; Rabe A
    Indian Heart J; 1998 Oct; 50 Suppl 1():62-6. PubMed ID: 9824909
    [No Abstract]   [Full Text] [Related]  

  • 19. Covered stent grafts: role in intervention of coronary arteries and degenerated vein grafts.
    Schächinger V; Zeiher AM
    Z Kardiol; 2002; 91 Suppl 3():58-63. PubMed ID: 12641016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polytetrafluoroethylene-covered stent for the treatment of narrowings in aorticocoronary saphenous vein grafts.
    Briguori C; De Gregorio J; Nishida T; Adamian M; Albiero R; Tucci G; Di Mario C; Colombo A
    Am J Cardiol; 2000 Aug; 86(3):343-6. PubMed ID: 10922449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.